J Ellegood1, S P Petkova2,3, J L Silverman2, J P Lerch4,5, A Kinman4, L R Qiu5, A Adhikari2, A A Wade3, D Fernandes4,6, Z Lindenmaier4,6, A Creighton7, L M J Nutter7, A S Nord2,3,8. 1. Mouse Imaging Centre (MICe), Hospital for Sick Children, 25 Orde Street, Toronto, ON, M5T 3H7, Canada. jacob.ellegood@sickkids.ca. 2. Department of Psychiatry and Behavioral Sciences, MIND Institute, School of Medicine, University of California, Davis, Sacramento, CA, USA. 3. Neuroscience Graduate Group, University of California - Davis, Davis, CA, USA. 4. Mouse Imaging Centre (MICe), Hospital for Sick Children, 25 Orde Street, Toronto, ON, M5T 3H7, Canada. 5. Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neuroscience, The University of Oxford, Oxford, UK. 6. Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. 7. The Centre for Phenogenomics, Hospital for Sick Children, Toronto, ON, Canada. 8. Department of Neurobiology, Physiology and Behavior, University of California - Davis, Davis, CA, USA.
Abstract
BACKGROUND: One of the causal mechanisms underlying neurodevelopmental disorders (NDDs) is chromatin modification and the genes that regulate chromatin. AT-rich interactive domain 1B (ARID1B), a chromatin modifier, has been linked to autism spectrum disorder and to affect rare and inherited genetic variation in a broad set of NDDs. METHODS: A novel preclinical mouse model of Arid1b deficiency was created and validated to characterize and define neuroanatomical, behavioral and transcriptional phenotypes. Neuroanatomy was assessed ex vivo in adult animals and in vivo longitudinally from birth to adulthood. Behavioral testing was also performed throughout development and tested all aspects of motor, learning, sociability, repetitive behaviors, seizure susceptibility, and general milestones delays. RESULTS: We validated decreased Arid1b mRNA and protein in Arid1b+/- mice, with signatures of increased axonal and synaptic gene expression, decreased transcriptional regulator and RNA processing expression in adult Arid1b+/- cerebellum. During neonatal development, Arid1b+/- mice exhibited robust impairments in ultrasonic vocalizations (USVs) and metrics of developmental growth. In addition, a striking sex effect was observed neuroanatomically throughout development. Behaviorally, as adults, Arid1b+/- mice showed low motor skills in open field exploration and normal three-chambered approach. Arid1b+/- mice had learning and memory deficits in novel object recognition but not in visual discrimination and reversal touchscreen tasks. Social interactions in the male-female social dyad with USVs revealed social deficits on some but not all parameters. No repetitive behaviors were observed. Brains of adult Arid1b+/- mice had a smaller cerebellum and a larger hippocampus and corpus callosum. The corpus callosum increase seen here contrasts previous reports which highlight losses in corpus callosum volume in mice and humans. LIMITATIONS: The behavior and neuroimaging analyses were done on separate cohorts of mice, which did not allow a direct correlation between the imaging and behavioral findings, and the transcriptomic analysis was exploratory, with no validation of altered expression beyond Arid1b. CONCLUSIONS: This study represents a full validation and investigation of a novel model of Arid1b+/- haploinsufficiency throughout development and highlights the importance of examining both sexes throughout development in NDDs.
BACKGROUND: One of the causal mechanisms underlying neurodevelopmental disorders (NDDs) is chromatin modification and the genes that regulate chromatin. AT-rich interactive domain 1B (ARID1B), a chromatin modifier, has been linked to autism spectrum disorder and to affect rare and inherited genetic variation in a broad set of NDDs. METHODS: A novel preclinical mouse model of Arid1b deficiency was created and validated to characterize and define neuroanatomical, behavioral and transcriptional phenotypes. Neuroanatomy was assessed ex vivo in adult animals and in vivo longitudinally from birth to adulthood. Behavioral testing was also performed throughout development and tested all aspects of motor, learning, sociability, repetitive behaviors, seizure susceptibility, and general milestones delays. RESULTS: We validated decreased Arid1b mRNA and protein in Arid1b+/- mice, with signatures of increased axonal and synaptic gene expression, decreased transcriptional regulator and RNA processing expression in adult Arid1b+/- cerebellum. During neonatal development, Arid1b+/- mice exhibited robust impairments in ultrasonic vocalizations (USVs) and metrics of developmental growth. In addition, a striking sex effect was observed neuroanatomically throughout development. Behaviorally, as adults, Arid1b+/- mice showed low motor skills in open field exploration and normal three-chambered approach. Arid1b+/- mice had learning and memory deficits in novel object recognition but not in visual discrimination and reversal touchscreen tasks. Social interactions in the male-female social dyad with USVs revealed social deficits on some but not all parameters. No repetitive behaviors were observed. Brains of adult Arid1b+/- mice had a smaller cerebellum and a larger hippocampus and corpus callosum. The corpus callosum increase seen here contrasts previous reports which highlight losses in corpus callosum volume in mice and humans. LIMITATIONS: The behavior and neuroimaging analyses were done on separate cohorts of mice, which did not allow a direct correlation between the imaging and behavioral findings, and the transcriptomic analysis was exploratory, with no validation of altered expression beyond Arid1b. CONCLUSIONS: This study represents a full validation and investigation of a novel model of Arid1b+/- haploinsufficiency throughout development and highlights the importance of examining both sexes throughout development in NDDs.
Entities:
Keywords:
Arid1b; Autism; Behavior; Coffin–Siris syndrome; Magnetic resonance imaging; Mouse
Authors: Kamila U Szulc; Jason P Lerch; Brian J Nieman; Benjamin B Bartelle; Miriam Friedel; Giselle A Suero-Abreu; Charles Watson; Alexandra L Joyner; Daniel H Turnbull Journal: Neuroimage Date: 2015-05-30 Impact factor: 6.556
Authors: Andrea L Gompers; Linda Su-Feher; Jacob Ellegood; Nycole A Copping; M Asrafuzzaman Riyadh; Tyler W Stradleigh; Michael C Pride; Melanie D Schaffler; A Ayanna Wade; Rinaldo Catta-Preta; Iva Zdilar; Shreya Louis; Gaurav Kaushik; Brandon J Mannion; Ingrid Plajzer-Frick; Veena Afzal; Axel Visel; Len A Pennacchio; Diane E Dickel; Jason P Lerch; Jacqueline N Crawley; Konstantinos S Zarbalis; Jill L Silverman; Alex S Nord Journal: Nat Neurosci Date: 2017-06-26 Impact factor: 24.884
Authors: Elizabeth L Berg; Stela P Petkova; Heather A Born; Anna Adhikari; Anne E Anderson; Jill L Silverman Journal: Mol Autism Date: 2021-09-15 Impact factor: 7.509
Authors: Luca Pagliaroli; Patrizia Porazzi; Alyxandra T Curtis; Chiara Scopa; Harald M M Mikkers; Christian Freund; Lucia Daxinger; Sandra Deliard; Sarah A Welsh; Sarah Offley; Connor A Ott; Bruno Calabretta; Samantha A Brugmann; Gijs W E Santen; Marco Trizzino Journal: Nat Commun Date: 2021-11-09 Impact factor: 14.919
Authors: Sunjay Sethi; Kimberly P Keil Stietz; Anthony E Valenzuela; Carolyn R Klocke; Jill L Silverman; Birgit Puschner; Isaac N Pessah; Pamela J Lein Journal: Front Neurosci Date: 2021-12-06 Impact factor: 4.677
Authors: Ahmed H Al-Amri; Paul Armstrong; Mascia Amici; Clemence Ligneul; James Rouse; Mohammed E El-Asrag; Andreea Pantiru; Valerie E Vancollie; Hannah W Y Ng; Jennifer A Ogbeta; Kirstie Goodchild; Jacob Ellegood; Christopher J Lelliott; Jonathan G L Mullins; Amanda Bretman; Ruslan Al-Ali; Christian Beetz; Lihadh Al-Gazali; Aisha Al Shamsi; Jason P Lerch; Jack R Mellor; Abeer Al Sayegh; Manir Ali; Chris F Inglehearn; Steven J Clapcote Journal: Biol Psychiatry Date: 2022-01-11 Impact factor: 12.810
Authors: Anna Adhikari; Fiona K B Buchanan; Timothy A Fenton; David L Cameron; Julian A N M Halmai; Nycole A Copping; Kyle D Fink; Jill L Silverman Journal: Hum Mol Genet Date: 2022-09-10 Impact factor: 5.121
Authors: Stela P Petkova; Anna Adhikari; Elizabeth L Berg; Timothy A Fenton; Jessica Duis; Jill L Silverman Journal: Autism Res Date: 2022-03-10 Impact factor: 4.633